Guanmin Meng

Guanmin Meng

Auto-generated profile, based on publicly available information

Guanmin Meng

Division of Gastroenterology, Department of Medicine, University of Alberta , Edmonton, AB

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2015 in Oncology Reports
Verified
Journal Article
Open access
PDF file
KJKai Jiang
Kai Jiang
WWWei Wang
Wei Wang
XJXin Jin
Xin Jin
ZWZhaoyang Wang
Zhaoyang Wang
ZJZhiwei Ji
Zhiwei Ji
GMGuanmin Meng
Guanmin Meng
Silibinin, derived from the milk thistle plant (Silybum marianum), has anticancer and chemopreventive properties. Silibinin has been reported to inhibit the growth of various types of cancer cells. However, the mechanisms by which silibinin exerts an anticancer effect are poorly defined. The present study aimed to investigate whether silibinin-induced cell death might be attributed to autophagy and the underlying mechanisms in human MCF7 breast cancer cells. Our results showed that silibinin-induced cell death was greatly abrogated by two specific autophagy inhibitors, 3-methyladenine (3-MA) and bafilomycin-A1 (Baf-A1). In addition, silibinin triggered the conversion of light chain 3 (LC3)-I to LC3-II, promoted the upregulation of Atg12-Atg5 formation, increased Beclin-1 expression, and decreased the Bcl-2 level. Moreover, we noted elevated reactive oxygen species (ROS) generation, concomitant with the dissipation of mitochondrial transmembrane potential (ΔΨm) and a drastic decline in ATP levels following silibinin treatment, which were effectively prevented by the antioxidants, N-acetylcysteine and ascorbic acid. Silibinin stimulated the expression of Bcl-2 adenovirus E1B 19-kDa-interacting protein 3 (BNIP3), a pro-death Bcl-2 family member, and silencing of BNIP3 greatly inhibited silibinin-induced cell death, decreased ROS production, and sustained ΔΨm and ATP levels. Taken together, these findings revealed that silibinin induced autophagic cell death through ROS-dependent mitochondrial dysfunction and ATP depletion involving BNIP3 in MCF7 cells.


7 January 2015 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
GMGuanmin Meng
Guanmin Meng
WWWei Wang
Wei Wang
KCKequn Chai
Kequn Chai
SYSuwen Yang
Suwen Yang
FLFangqiong Li
Fangqiong Li
KJKai Jiang
Kai Jiang
Lung cancer is the leading cause of cancer death worldwide. Recently, two plant-derived drugs triptolide (TP) and hydroxycamptothecin (HCPT) both have shown broad-spectrum anticancer activities. Our previous study documented that combination treatment with these two drugs acted more effectively than mono-therapy, however, the molecular basis underlying the synergistic cytotoxicity remains poorly understood. In this study, we aimed to clarify the molecular mechanism of TP/HCPT anticancer effect in A549 lung adenocarcinoma cells, by investigating the involvement of phosphatase 2A (PP2A) and PP2A-regulated mitogen-activated protein kinases (MAPKs) and Akt signaling pathways. The results showed that TP and HCPT synergistically exerted cytotoxicity in the growth of A549 cells. Combinatorial TP/HCPT treatment significantly enhanced the activation of caspase-3 and -9, Bax/Bcl-2 ratio, release of cytochrome c from mitochondrial and subsequent apoptosis. While the Akt survival pathway was inhibited, ERK and p38 MAPKs were dramatically activated. Furthermore, the activity of PP2A was significantly augmented. Regulation of p38, ERK and Akt by PP2A was demonstrated, by using a specific PP2A inhibitor okadaic acid (OA). Finally, pharmacological inhibitors OA, SB203580, SP600125 and PD98059 confirm the role of PP2A and its substrates ERK, p38 MAPK and Akt in mediating TP/HCPT-induced apoptosis. Taken together, this study provides the first evidence for a synergistic TP/HCPT anticancer activity in A549 cells and also supports a critical role of PP2A and PP2A-regulated signaling pathways, providing new insight into the mode of action of TP/HCPT in cancer therapy.

1 September 2016 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
GMGuanmin Meng
Guanmin Meng
KCKequn Chai
Kequn Chai
XLXinda Li
Xinda Li
YZYongqiang Zhu
Yongqiang Zhu
WHWeihua Huang
Weihua Huang

1 December 2011 in Toxicology Letters
Verified
Journal Article
Closed access
YSYu Sun
Yu Sun
GMGuan-Min Meng
Guan-Min Meng
ZGZong-Lou Guo
Zong-Lou Guo
LXLi-Hong Xu
Li-Hong Xu

19 October 2013 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
GMGuanmin Meng
Guanmin Meng
JLJinghui Liu
Jinghui Liu
SLShuyan Lin
Shuyan Lin
ZGZonglou Guo
Zonglou Guo
LXLihong Xu
Lihong Xu